Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

Article Article scientifique Article Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population eng 2003 author Jaggy Christian author von Overbeck Jan author Ledergerber Bruno author Schwarz Claude 510302 author Egger Mathias 108202 author Rickenbach Martin author Furrer Hansjakob author Telenti Amalio author Battegay Manuel author Flepp Markus author Vernazza Pietro author Bernasconi Enos 663410 author Hirschel Bernard 22746 877-878 10.1016/S0140-6736(03)14307-3 13678976 0140-6736 Because of high death rates in the past, patients with HIV-1 cannot obtain life insurance. We measured mortality rates in the Swiss HIV Cohort Study (SHCS) from 1997 to 2001 and compared them with those of the Swiss reference population. In patients who were successfully treated with highly active anti-retroviral therapy (HAART), and who were not also infected with the hepatitis C virus, excess death rates were below five per thousand per year. Patients with successfully treated cancer have much the same excess death rates but are not excluded from life insurance policies. Adult Antiretroviral Therapy, Highly Active Cohort Studies Comorbidity Female Follow-Up Studies HIV Infections/drug therapy/epidemiology/ mortality Hiv-1 Hepatitis C/epidemiology/mortality Humans Insurance, Life/statistics & numerical data Male Mortality Switzerland/epidemiology Treatment Outcome Dewey 616 56 Département de médecine 221 false Lancet 362 9387 0dc8bdb4-96b6-4d8b-88bc-dafa9706828d Article Restricted file1.pdf 62527 application/pdf restrictedAccess Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Year	Views	Downloads

Régulation de la production de cytokines par le tissu adipeux in vivo		2006	1,482	906
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population	Lancet	2003	541	0

Archive ouverte UNIGE

Schwarz, Claude